21185 ⎘
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies Veterinary vaccine
Vaccine delivery method
#1202BVDV vaccine
#1203Vaccine for protection against and Porcine circo virus
#1204Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
#1205Oral vaccination of fish with live attenuated vaccines
#1206Cholera toxin chimera and its use as a staph vaccine
#1207Immunisation of large mammals with low doses of RNA
#1208Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#1209Modified live-attenuated vaccines (MLV) created by DNA shuffling against porcine reproductive and respiratory syndrome virus (PRRSV)
#1210Marker vaccine for classical swine fever
#1211Peptide for reducing the phosphate requirement and excretion from farm animals
#1212Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
#1213Compositions for transfection of biomolecules into cells
#1214Vaccine produced using optimized immobilization antigen cDNA of cryptocaryon irritans and producing method and use thereof
#1215Campylobacter polypeptides and methods of use
#1216Parasite vaccine
#1217VACCINE AGAINST MYCOPLASMA, HYOPNEUMONIAE, SUITABLE FOR ADMINISTRATION IN THE PRESENCE OF MATERNALLY DERIVED ANTIBODIES
#1218Bacterial vaccine components from and uses thereof
#1219Method of rapidly producing improved vaccines for animals
#1220Piscine reovirus immunogenic compositions
#1221vaccine
#1222ATTENUATED FISH VACCINE FOLLOWING CULTURE IN IRON LIMITED MEDIA
#1223Vaccine for protection against
#1224Methods and compositions to protect aquatic invertebrates from disease
#1225VACCINE COMPRISING INACTIVATED CELLS OF HAEMOPHILUS PARASUIS BACTERIA OF SEROTYPE 5
#1226Bovine herpes virus vaccine with multiple mutations
#1227Genetically engineered swine influenza virus and uses thereof
#1228RECOMBINANT MULTIMERIC INFLUENZA PROTEINS
#1229PRRS virus inducing type I interferon in susceptible cells
#1230Interleukin-31 monoclonal antibody
#1231Avirulent variants and pharmaceutical composition using the same
#1232ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS
#1233Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#1234ADJUVANT DILUENTS FOR LIVE VACCINES FOR PIG DISEASES
#1235ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS
#1236IN SITU CONSTITUTING A VACCINE FOR ADMINISTRATION TO A PREDETERMINED HERD OF ANIMALS
#1237Recombinant attenuated parvovirus
#1238Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen
#1239T CELL THERAPY FOR B CELL LYMPHOMA
#1240Live vaccine for avian diseases
#1241Infectious clones of torque teno virus
#1242Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
#1243Needle-free administration of PRRSV vaccines
#1244Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
#1245Vaccine
#1246Avirulent variants and pharmaceutical composition using the same
#1247Vaccine and health-related applications for ruminant breath monitoring system
#1248Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#1249ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI
#1250Pneumovirus compositions and methods for using the same
#1251Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#1253Vaccines containing canine parvovirus genetic variants
#1254Combination of protein forms for hornfly vaccination
#1255Cytolytic RTX-Toxin From Gallibacterium Anatis
#1256Attenuated live vaccines for aquatic animals
#1257Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#1258VACCINE PEPTIDES
#1259Diagnostic, therapeutic and a vaccine against treponemes
#1260COMPOSITIONS AND METHODS FOR CONTROLLING DISEASES IN ANIMALS
#1261Vaccination of sex reversed hybrid tilapia (x ) with an inactivated vaccine
#1262INACTIVATED POULTRY VACCINE
#1263Modified live (JMSO strain) vaccine
#1264Immune system modulating composition
#1265bacterin vaccine
#1266European PRRSV strain
#1267Efficient mucosal vaccination mediated by the neonatal Fc receptor
#1268Commercial scale process for production of PRRSV
#1269Immunizing Compositions and Methods of Use
#1270Immunizing compositions and methods of use
#1271Vaccines comprising heat-sensitive transgenes
#1272Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
#1273Modified gram-negative bacteria for use as vaccines
#1274Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
#1275Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#1276Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#1277VACCINATION FOR LAWSONIA INTRACELLULARIS
#1278COMPOSITIONS AND METHODS FOR VACCINATING CATTLE
#1279METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS
#1280Live bacterial vaccines for viral infection prophylaxis or treatment
#1281Canine Lyme disease vaccine
#1282Temperature sensitive vaccine strain of and uses thereof
#1283Vaccine Compositions
#1284VACCINE DIRECTED AGAINST PORCINE PLEUROPNEUMONIA AND A METHOD TO OBTAIN SUCH A VACCINE
#1285Chimeric viruses presenting non-native surface proteins and uses thereof
#1286SUPRALINGUAL VACCINES AND APPLICATORS
#1287Sticky soft gel for treating poultry
#1288VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS
#1289Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
#1290Methods and compositions to protect aquatic invertebrates from disease
#1291FELINE INFECTIOUS PERITONITIS VACCINE
#1292METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS
#1293VIRAL VACCINE AND PROCESS FOR PREPARING THE SAME
#1294In ovo vaccination of in avian species
#1295Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#1296presenting N-glycan or derivatives thereof
#1297Composition comprising sortase anchored surface proteins of
#1298Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof
#1299Use of antigen
#1300Method for keeping an immunogenic composition available for administration to an animal
#1301Methods and compositions for treating and preventing Shiga toxin-producing infection
#1302E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
#1303Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
#1304METHOD FOR KEEPING A FOOT-AND-MOUTH DISEASE VACCINE AVAILABLE FOR EMERGENCY VACCINATION
#1305ENHANCED IMMUNE RESPONSE IN AVIAN SPECIES
#1306Potomac horse fever isolates
#1307Newcastle disease virus vectored herpesvirus vaccines
#1308Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
#1309Poultry viral materials and methods related thereto
#1310Vaccine
#1311Circovirus sequences associated with piglet weight loss disease (PWD)
#1312Bovine herpes virus-1 compositions, vaccines and methods
#1313E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines
#1314formulation
#1315Vaccine for protection against bacteria of various serotypes
#1316MARKED BOVINE VIRAL DIARRHEA VIRUS VACCINES
#1317N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1318Low antigen-dose immunization for maximizing T-helper cell 1 (Th1) immunity against a pathogen
#1319Circovirus sequences associated with piglet weight loss disease (PWD)
#1320Compositions Produced Using Enteric Pathogens and Methods of Use
#1321RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA
#1322Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease
#1323Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic
#1324AVIAN VACCINES POSSESSING A POSITIVE MARKER GENE
#1325Compositions and dosage regimes comprising a clostridial vaccine and levamisole
#1326Materials and methods for respiratory disease control in canines
#1327RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#1328Vaccine
#1329Infectious bronchitis vaccines derived from IB-QX-like vaccine strains
#1330Method for the oral/mucosal vaccination by means of recombinant yeasts
#1331Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#1332Porcine Adenovirus 3-Based PRRSV Vaccines
#1333RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI
#1334Live attenuated chimeric porcine circovirus vaccine
#1335PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
#1336IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES
#1337RABIES VACCINE
#1338Vaccine preparation for neospora caninum infection
#1339Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
#1340Bluetongue virus recombinant vaccines and uses thereof
#1341Recombinant CDV compositions and uses thereof
#1342FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF
#1343COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS
#1344Soft gel delivery system for treating poultry
#1345Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#1346Monoclonal antibodies directed to CD20
#1347Inactivated chimeric vaccines and related methods of use
#1348Immunizing compositions and methods of use
#1349Anti-FMD vaccine composition and preparation and use thereof
#1350Yersinia SPP. Polypeptides and Methods of Use
#1351VETERINARY PHARMACEUTICAL FORMULACION THAT COMPRISES AN RNA RECOMBINANT PARTICLE THAT ENCODES FOR A CU/ZN SUPEROXIDE DISMUTASE PROTEIN OF RUMINANT PATHOGENIC BACTERIA AND AT LEAST ONE RNA ALPHAVIRUS BELONGING TO THE SEMLIKI FOREST VIRUS FAMILY
#1352Immunizing compositions and methods of use
#1353Immunizing compositions and methods of use
#1354PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF
#1355Attenuated strains
#1356Prevention and treatment of sub-clinical PCVD
#1357DIVA (differentiate infected from vaccinated animals)
#1358Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region
#1359Methods of immunizing pregnant heifers at three months of gestation
#1360Astrovirus
#1361Piscirickettsia salmonis antigens and use thereof
#1362Vaccines for inclusion body hepatitis
#1363Rabies virus-based recombinant immunocontraceptive compositions and methods of use
#1364Method and composition for delivery of medicants to animals
#1365METHOD AND COMPOSITION FOR DELIVERY OF MEDICANTS TO ANIMALS
#1366Recombinant NDV antigen and uses thereof
#1367West Nile Virus vaccine
#1368Compositions and methods of enhancing immune responses to flagellated bacterium
#1369Methods and Compositions for control of disease in aquaculture
#1370DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION
#1371Avian reoviridae and vaccines thereof
#1372Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides
#1373MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE
#1374Circovirus sequences associated with piglet weight loss disease (PWD)
#1375Fish vaccine
#1376TREATMENT OF PRDC IN PIGS
#1377Vaccine formulations comprising saponin-containing adjuvants
#1378IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS
#1379antigens
#1380Infectious bursal disease virus antigenic isolates and vaccines
#1381Immunologically active compositions
#1382Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS)
#1383ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
#1384HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
#1385INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#1386Heterologous protection against provided by fur cells and the outer-membrane protein extracts thereof
#1387Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
#1388CYCLIZED NON-NATIVE SYNTHETIC PEPTIDE AND COMPLEX OF PEPTIDES COMPRISING SAID CYCLIZED PEPTIDE, INTENDED TO INDUCE AND TO CHARACTERIZE THE PREVENTION OR TREATMENT OF CONDITIONS IN MAMMALS
#1389Method of inducing tolerance to an allergen
#1390Virus-like particles as vaccines for paramyxovirus
#1391POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO
#1392Inactivated Live-Attenuated Bluetongue Virus Vaccine
#1393Treatment of pigs with PCV2 antigent
#1394NOVEL VACCINE FOR DOG
#1395Process and formulation for immunizing fish in aquaculture systems
#1396Recombinant avian paramyxovirus vaccine and method for making and using thereof
#1397MULTI EPITOPE VACCINE FOR POULTRY
#1398Vaccine Antigens from Piscirickettsia Salmonis
#1399CDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS
#1400Attenuated vaccine against fish pathogen sp
#1401PCV-2 vaccine
#1402Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies
#1403Sequences of , immunogenic compounds, methods for preparation and use thereof
#1404VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)
#1405Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity
#1406LIVE ATTENUATED SALMONELLA VACCINE
#1407Methods of reducing concomitant infections in pigs with a PCV2 antigen
#1408Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#1409Porcine torque teno virus vaccines and diagnosis
#1410Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1411-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1412VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS
#1413VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS
#1414METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
#1415Circovirus sequences associated with piglet weight loss disease (PWD)
#1416Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof
#1417Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#1418Compositions and methods of enhancing immune responses
#1419COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES
#1420Determination of antigenicity of an inactivated virus
#1421IMMUNIZING COMPOSITION
#1422Genes and proteins of and uses thereof
#1423Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1424Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets
#1425CHIMERIC FOOT AND MOUTH DISEASE VIRUSES
#1426Cross-reactive determinants and methods for their identification
#1427Anti-VEGF antibodies
#1428Immunogenic compositions containing H7 flagella and methods of use thereof
#1429Transgenic plants expressing STX2EB protein for use as a pig edema disease vaccine
#1430Vaccine Antigens
#1431Immunoreactive glycoprotein GP19
#1432Method for producing vaccinal viral strain of a virus of the reoviridae family
#1433DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#1434Subunit vaccine for aquaculture
#1435strain
#1436Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
#1437Canine influenza virus and vaccine therefore
#1438Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
#1439PRRSV compositions
#1440Method of preventing early infections
#1441Macrocyclic lactone combination compositions, vaccines and methods for producing same
#1442alpha toxin proteins
#1443Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
#1444Stabilizers for freeze-dried vaccines
#1445Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#1446Modified live (JMSO strain) vaccine
#1447Newcastle disease virus vectored avian vaccines
#1448Vaccine against
#1449Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
#1450Composition and method for controlling intestinal pathogenic organisms
#1451Attenuated ehrlichiosis vaccine
#1452METHODS OF SELECTING HOST RESISTANT ANIMALS
#1453NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#1454Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
#1455CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1456Circovirus sequences associated with piglet weight loss disease (PWD)
#1457Recombinant vaccine against West Nile Virus
#1458KENNEL COUGH VACCINE
#1459CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1460PROTECTION OF AN ANIMAL AGAINST PESTIVIRUS INFECTION
#1461Nucleic acid and amino acid sequences, and vaccine for the control of ectoparasite infestations in fish
#1462Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1463CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1464STREPTOCOCCUS M PROTEIN, IMMUNOGENIC FRAGMENTS, NUCLEIC ACIDS AND METHODS OF USE
#1465Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
#1466METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#1467CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1468CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1469CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1470Circovirus sequences associated with piglet weight loss disease (PWD)
#1471CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1472CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1473CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1474CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1475Use of coccidian
#1476Attenuated recombinant newcastle disease virus and vaccine containing the same
#1477Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system
#1478Method of treating pregnant cows and/or heifers
#1479CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1480Method of inducing immune tolerance to type I diabetes
#1481vaccine for turkeys
#1482CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1483Culturing circular ssDNA viruses for the production of vaccines
#1484ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#1485PCV 2-Based Methods and Compositions for the Treatment of Pigs
#1486Methods and Compositions for Use of a Coccidiosis Vaccine
#1487METHODS OF PREDICTING CANCER LETHALITY USING REPLIKIN COUNTS
#1488Compositions and methods for controlling diseases in animals
#1489METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS
#1490METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#1491METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS
#1492Chimeric pestiviruses
#1493N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
#1494METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#1495Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
#1496Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof
#1497Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same
#1498Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome
#1499EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
#1500Vaccine against african horse sickness virus